Back
CI DoubleLine Total Rtn Bd US$ ETF US$ Vs. NovoCure Industry Stock Comparison
Buy
82
CDLB.U.TO
CI DoubleLine Total Rtn Bd US$ ETF US$
Last Price:
17.34
Seasonality Move:
-0.53%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Buy
82
CI DoubleLine Total Rtn Bd US$ ETF US$ (CDLB.U.TO)
is a Buy
Is CI DoubleLine Total Rtn Bd US$ ETF US$ a Buy, Sell or Hold?
- The current CI DoubleLine Total Rtn Bd US$ ETF US$ [CDLB.U.TO] share price is $17.34. The Score for CDLB.U.TO is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- CDLB.U.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CDLB.U.TO Stock Price Chart
What is CI DoubleLine Total Rtn Bd US$ ETF US$'s stock price today?
-
The CI DoubleLine Total Rtn Bd US$ ETF US$ share price today is $17.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDLB.U.TO is experiencing slight buying pressure.
CDLB.U.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 87.07 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.16 - 17.32) | Buy |
Bollinger Bands (100): | (17.14 - 17.24) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.78 | Buy |
Relative Strength Index (14 RSI): | 75.34 | Buy |
Chaikin Money Flow: | 1118573 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.36 - 28.56) | Buy |
Bollinger Bands (100): | (14.7 - 22.78) | Buy |
CDLB.U.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.34 | Sell |
20-day SMA: | 17.25 | Buy |
50-day SMA: | 17.21 | Buy |
200-day SMA: | 17.04 | Buy |
8-day EMA: | 17.32 | Buy |
20-day EMA: | 17.28 | Buy |
50-day EMA: | 17.22 | Buy |
200-day EMA: | 17.08 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.6 | Buy |
20-day SMA: | 23.68 | Buy |
50-day SMA: | 19.33 | Buy |
200-day SMA: | 17.9 | Buy |
8-day EMA: | 29.53 | Buy |
20-day EMA: | 25.45 | Buy |
50-day EMA: | 21.38 | Buy |
200-day EMA: | 19.88 | Buy |
CI DoubleLine Total Rtn Bd US$ ETF US$ Earnings Growth & CDLB.U.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
CI DoubleLine Total Rtn Bd US$ ETF US$ Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |